Eintrag weiter verarbeiten
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
Gespeichert in:
| Zeitschriftentitel: | British Journal of Cancer |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , |
| In: | British Journal of Cancer, 102, 2010, 6, S. 981-986 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Springer Science and Business Media LLC
|
| Schlagwörter: |
| author_facet |
Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L |
|---|---|
| author |
Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L |
| spellingShingle |
Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L British Journal of Cancer Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Cancer Research Oncology |
| author_sort |
hsu, c-h |
| spelling |
Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L 0007-0920 1532-1827 Springer Science and Business Media LLC Cancer Research Oncology http://dx.doi.org/10.1038/sj.bjc.6605580 Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma British Journal of Cancer |
| doi_str_mv |
10.1038/sj.bjc.6605580 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5iamMuNjYwNTU4MA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5iamMuNjYwNTU4MA |
| institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 |
| imprint |
Springer Science and Business Media LLC, 2010 |
| imprint_str_mv |
Springer Science and Business Media LLC, 2010 |
| issn |
0007-0920 1532-1827 |
| issn_str_mv |
0007-0920 1532-1827 |
| language |
English |
| mega_collection |
Springer Science and Business Media LLC (CrossRef) |
| match_str |
hsu2010efficacyandtolerabilityofbevacizumabpluscapecitabineasfirstlinetherapyinpatientswithadvancedhepatocellularcarcinoma |
| publishDateSort |
2010 |
| publisher |
Springer Science and Business Media LLC |
| recordtype |
ai |
| record_format |
ai |
| series |
British Journal of Cancer |
| source_id |
49 |
| title |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_unstemmed |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_full |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_fullStr |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_full_unstemmed |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_short |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_sort |
efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1038/sj.bjc.6605580 |
| publishDate |
2010 |
| physical |
981-986 |
| description |
|
| container_issue |
6 |
| container_start_page |
981 |
| container_title |
British Journal of Cancer |
| container_volume |
102 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344588345671680 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:06:44.152Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Efficacy+and+tolerability+of+bevacizumab+plus+capecitabine+as+first-line+therapy+in+patients+with+advanced+hepatocellular+carcinoma&rft.date=2010-03-01&genre=article&issn=1532-1827&volume=102&issue=6&spage=981&epage=986&pages=981-986&jtitle=British+Journal+of+Cancer&atitle=Efficacy+and+tolerability+of+bevacizumab+plus+capecitabine+as+first-line+therapy+in+patients+with+advanced+hepatocellular+carcinoma&aulast=Cheng&aufirst=A-L&rft_id=info%3Adoi%2F10.1038%2Fsj.bjc.6605580&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344588345671680 |
| author | Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L |
| author_facet | Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L, Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L |
| author_sort | hsu, c-h |
| container_issue | 6 |
| container_start_page | 981 |
| container_title | British Journal of Cancer |
| container_volume | 102 |
| description | |
| doi_str_mv | 10.1038/sj.bjc.6605580 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5iamMuNjYwNTU4MA |
| imprint | Springer Science and Business Media LLC, 2010 |
| imprint_str_mv | Springer Science and Business Media LLC, 2010 |
| institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105 |
| issn | 0007-0920, 1532-1827 |
| issn_str_mv | 0007-0920, 1532-1827 |
| language | English |
| last_indexed | 2024-03-01T17:06:44.152Z |
| match_str | hsu2010efficacyandtolerabilityofbevacizumabpluscapecitabineasfirstlinetherapyinpatientswithadvancedhepatocellularcarcinoma |
| mega_collection | Springer Science and Business Media LLC (CrossRef) |
| physical | 981-986 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Springer Science and Business Media LLC |
| record_format | ai |
| recordtype | ai |
| series | British Journal of Cancer |
| source_id | 49 |
| spelling | Hsu, C-H Yang, T-S Hsu, C Toh, H C Epstein, R J Hsiao, L-T Chen, P-J Lin, Z-Z Chao, T-Y Cheng, A-L 0007-0920 1532-1827 Springer Science and Business Media LLC Cancer Research Oncology http://dx.doi.org/10.1038/sj.bjc.6605580 Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma British Journal of Cancer |
| spellingShingle | Hsu, C-H, Yang, T-S, Hsu, C, Toh, H C, Epstein, R J, Hsiao, L-T, Chen, P-J, Lin, Z-Z, Chao, T-Y, Cheng, A-L, British Journal of Cancer, Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma, Cancer Research, Oncology |
| title | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_full | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_fullStr | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_full_unstemmed | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_short | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_sort | efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| title_unstemmed | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1038/sj.bjc.6605580 |